N-(5-Bromo-4-methylpyridin-2-yl)acetamide, 95.0%, 5g

(6-Isopropyl-9-methyl-1,4-dioxaspiro[4.5]Decan-2-yl)methanol, 98%, 25g

1-Methanesulfonylpiperazine, 97.0%, 1g

Benzyl 5-aminopentanoate hydrochloride, 95%, 5g

Trial kit Spectra/Por® 1-3 Spectra/Por® 2 - MWCO 12,000–14,000, 45 mm, 1 Piece(s)

1,2-Dimethylimidazole, 99.00%, 250g

(R)-5-Hydroxypiperidin-2-one, 95.0%, 100mg

4-Chloro-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-(2,2,2-trifluoroethyl)-1H-indazol-3-amine, 98%, 100mg

5-(5-BROMO-2-THIENYL)-1H-TETRAZOLE, 97%, 100mg

N-([1,1'-Biphenyl]-4-yl)dibenzo[b,d]thiophen-4-amine, 98%, 25g

2-Fluoro-6-nitrobenzonitrile, 95.0%, 25g

GC capillary column ROTI®Cap-5, 50 m, 0.20 mm, 0.50 µm, 1 Piece(s)

6-Bromo-8-fluoro-3,4-dihydronaphthalen-2(1H)-one, 98%, 1g